American Virtual Cloud (AVCTQ) 10-K 14 Jun 19 2019 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Mar. 31, 2019	Jun. 14, 2019	Sep. 28, 2018
Document And Entity Information
Entity Registrant Name	PENSARE ACQUISITION Corp
Entity Central Index Key	0001704760
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Document Type	10-K
Document Period End Date	Mar. 31, 2019
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2019
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filer	No
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Shell Company	true
Entity Ex Transition Period	false
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Public Float			$ 327,300,000
Entity Common Stock, Shares Outstanding		32,184,225
Entity File Number	001-38167

Balance Sheets

Balance Sheets - USD ($)	Mar. 31, 2019	Mar. 31, 2018
Current Assets
Cash	$ 135,265	$ 482,676
Cash and marketable securities held in Trust Account available to pay taxes	62,725	183,998
Prepaid expenses	10,398	76,360
Other current assets	12,266	32,499
Total Current Assets	220,654	775,533
Deferred tax asset	216,000
Office furniture and equipment, net of accumulated depreciation	13,734	17,393
Cash and marketable securities held in Trust Account	290,392,032	311,919,253
TOTAL ASSETS	290,842,420	312,712,179
Current Liabilities
Accounts payable and accrued expenses	5,214,351	2,818,894
Taxes payable	62,725	81,225
Promissory notes-related party	3,222,373
Total Current Liabilities	8,499,449	2,900,119
Commitments
Common stock subject to possible redemption, 26,984,101 and 30,342,514 shares at redemption value as of March 31, 2019 and March 31, 2018, respectively	277,342,970	304,812,059
Stockholders' Equity (Deficit)
Preferred stock, $0.001 par value; 1,000,000 authorized; none issued and outstanding
Common stock, $0.001 par value; 100,000,000 shares authorized; 9,032,109 and 8,469,986 shares issued and outstanding as of March 31, 2019 and March 31, 2018, (excluding 26,984,101 and 30,342,514 shares subject to possible redemption; respectively)	9,033	8,470
Additional paid-in capital	6,580,407	7,570,769
Accumulated deficit	(1,589,439)	(2,579,238)
Total Stockholders' Equity	5,000,001	5,000,001
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 290,842,420	$ 312,712,179

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2019	Mar. 31, 2018
Statement of Financial Position [Abstract]
Common stock subject to possible redemption	26,984,101	30,342,514
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, authorized	1,000,000	1,000,000
Preferred stock, issued
Preferred stock, outstanding
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized	100,000,000	100,000,000
Common stock, issued	9,032,109	8,469,986
Common stock, outstanding	9,032,109	8,469,986

Statements of Operations

Statements of Operations - USD ($)	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Income Statement [Abstract]
Operating costs	$ 4,507,961	$ 3,939,349
Loss from operations	(4,507,961)	(3,939,349)
Other income:
Interest income	5,281,923	1,603,302
Income (Loss) before provision for income taxes	773,962	(2,336,047)
Benefit (Provision) for income taxes	215,837	(183,998)
Net income (loss)	$ 989,799	$ (2,520,045)
Weighted average shares outstanding, basic and diluted	8,563,373	6,790,097
Basic and diluted net loss per common share	$ (0.45)	$ (0.58)

Statements of Changes in Stockh

Statements of Changes in Stockholders' Equity - USD ($)	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Total
Balance at Mar. 31, 2017	$ 11		$ (59,193)	$ (59,182)
Balance, shares at Mar. 31, 2017	10,800
Issuance of 7,751,700 Founders Shares	$ 7,752	17,238		24,990
Issuance of 7,751,700 Founders Shares, shares	7,751,700
Sales of 31,050,000 Units, net of underwriters' discount and offering expenses	$ 31,050	301,822,647		301,853,697
Sales of 31,050,000 Units, net of underwriters' discount and offering expenses, shares	31,050,000
Sale of 10,512,500 Placement Warrants		10,512,500		10,512,500
Unit Purchase Option		100		100
Ordinary shares subject to redemption	$ (30,343)	(304,781,716)		(304,812,059)
Ordinary shares subject to redemption, shares	(30,342,514)
Net Income			(2,520,045)	(2,520,045)
Balance at Mar. 31, 2018	$ 8,470	7,570,769	(2,579,238)	$ 5,000,001
Balance, shares at Mar. 31, 2018	8,469,986			8,469,986
Ordinary shares subject to redemption	$ 563	(990,362)		$ (989,799)
Ordinary shares subject to redemption, shares	562,123
Net Income			989,799	989,799
Balance at Mar. 31, 2019	$ 9,033	$ 6,580,407	$ (1,589,439)	$ 5,000,001
Balance, shares at Mar. 31, 2019	9,032,109			9,032,109

Statements of Changes in Stoc_2

Statements of Changes in Stockholders' Equity (Parenthetical) - Common Stock	12 Months Ended
	Mar. 31, 2018shares
Issuance of Founders Shares, shares	7,751,700
Sales of Units, net of underwriters' discount and offering expenses, shares	31,050,000
Sale of Placement Warrants, shares	10,512,500

Statements of Cash Flows

Statements of Cash Flows - USD ($)	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash Flows from Operating Activities:
Net income (loss)	$ 989,799	$ (2,520,045)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(5,281,923)	(1,603,251)
Depreciation	3,659	1,525
Deferred income taxes	(216,000)
Changes in operating assets and liabilities:
Prepaid expenses	65,962	(76,360)
Other current assets	20,233	(32,499)
Taxes payable	(18,500)	81,225
Accounts payable and accrued expenses	2,395,457	2,816,500
Net cash used in operating activities	(2,041,313)	(1,332,905)
Cash Flows from Investing Activities:
Withdrawal from Trust Account for taxes	336,274
Investment of cash in Trust Account	(1,864,745)	(310,500,000)
Shareholder redemption paid from Trust Account	28,458,888
Acquisition of fixed assets		(18,918)
Net cash provided by (used in) investing activities	26,930,417	(310,518,918)
Cash Flows from Financing Activities:
Proceed from issuance of common stock to initial shareholders		24,989
Proceeds from sale of Units, net of underwriting discounts paid		302,737,500
Proceeds from sale of Placement Units		10,512,500
Proceeds from UPO Sale		100
Payment of offering costs		(683,694)
Shareholder redemptions	(28,458,888)
Proceeds from promissory notes - related parties	3,222,373	277,881
Repayment of promissory notes - related parties		(543,339)
Net cash (used in) provided by financing activities	(25,236,515)	312,325,937
Net Change in Cash	(347,411)	474,114
Cash - Beginning	482,676	8,562
Cash - Ending	135,265	482,676
Supplemental Information
Interest paid
Income taxes paid	31,163	102,773
Non - Cash investing and financing activities:
Offering costs charged to additional paid-in capital		883,803
Initial classification of common stock subject to possible redemption		307,221,850
Change in value of common stock subject to possible redemption	$ 874,946	$ (2,409,791)

Description of Organization and

Description of Organization and Business Operations	12 Months Ended
	Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Pensare Acquisition Corp. (the "Company"), is a blank check company incorporated in Delaware on April 7, 2016. The Company was formed for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, recapitalization, exchangeable share transaction or other similar business transaction, one or more operating businesses or assets that the Company has not yet identified (a "Business Combination"). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses in the wireless telecommunications industry in the United States. All activity through March 31, 2019 relates to the Company's formation, its initial public offering ("Initial Public Offering") described below, identifying a target company for a Business Combination, and performing due diligence thereon. As previously disclosed in the current report on Form 8-K filed with the SEC on February 1, 2019, the Company entered into a Business Combination Agreement (the "Agreement") on January 31, 2019 with U.S. TelePacific Holdings Corp., d/b/a TPx Communications ("TPx") and Tango Merger Sub Corp. ("Merger Sub"), a wholly-owned subsidiary of the Company, relating to the proposed business combination between the Company and TPx. On May 20, 2019, the Company mutually agreed with TPx to terminate the Agreement pursuant to a Termination of Business Combination Agreement dated as of May 20, 2019, effective as of such date. As a result of the termination of the Agreement, effective as of May 20, 2019, the Agreement is of no further force or effect, and no party to the Agreement shall have any liability under the Agreement except as otherwise expressly set forth in the Agreement. The Company intends to continue to pursue a Business Combination. On January 28, 2019, at the Special Meeting in lieu of the 2019 Annual Meeting of the Company's Stockholders, the stockholders approved an amendment to its amended and restated certificate of incorporation to extend the date by which the Company has to consummate a business combination for an additional three months, from February 1, 2019 to May 1, 2019. The amendment was approved with 26,352,896 votes cast in favor of the amendment, 122,986 votes cast against the amendment and 323,175 abstentions. In connection with the special meeting and the resulting amendment to our amended and restated certificate of incorporation, 2,796,290 shares of our common stock were redeemed from funds available in the trust account established in connection with the Company's initial public offering (the "Trust Account"), for a redemption amount of approximately $10.18 per share. On April 22, 2019, the Company announced that its sponsor, had agreed to contribute as a loan, $0.033 for each share of common stock issued in the initial public offering that was not redeemed in connection with the stockholder vote to approve an amendment to the Company's amended and restated certificate of incorporation to extend the date by which it has to consummate a business combination for an additional three months, from May 1, 2019 to August 1, 2019. On April 29, 2019, at the Special Meeting of the Company's Stockholders, the stockholders approved an amendment to its amended and restated certificate of incorporation to extend the date by which the Company has to consummate a business combination for an additional three months, from May 1, 2019 to August 1, 2019. The amendment was approved with 26,163,835 votes cast in favor of the amendment, 2,020,001 votes cast against the amendment and 422,075 abstentions. In connection with the special meeting and the resulting amendment to our amended and restated certificate of incorporation, 3,831,985 shares of our common stock were redeemed from funds available in the Trust Account, for a redemption amount of approximately $10.33 per share. On May 31, 2019, the Company announced that the sponsor will reduce its contributions to the Trust Account. The sponsor will continue to pay to the Trust Account $0.033 per public share that has not been redeemed per month, but the total monthly payment will be no greater than $200,000. If more than 6,060,606 public shares remain outstanding after redemptions in connection with this adjustment, then the amount paid per share will be reduced proportionately. In connection with this announcement, the Company offered the public stockholders the right to redeem their shares of common stock for their pro rata The registration statements for the Company's Initial Public Offering were declared effective on July 27, 2017. On August 1, 2017, the Company consummated the Initial Public Offering of 27,000,000 units ("Units" and with respect to the shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), included in the Units, the "Public Shares") at $10.00 per Unit, generating gross proceeds of $270,000,000, which is described in Note 4. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 9,500,000 private placement warrants ("Private Placement Warrants") at a price of $1.00 per warrant in a private placement to the Company's sponsor, Pensare Sponsor Group, LLC (the "Sponsor"), MasTec, Inc. ("MasTec") and EarlyBirdCapital, Inc. ("EBC"), generating gross proceeds of $9,500,000, which is described in Note 5. Following the closing of the Initial Public Offering on August 1, 2017, an amount of $270,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Warrants was placed in a trust account (the "Trust Account") and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the "Investment Company Act"), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account, as described below, except that interest earned on the Trust Account can be released to pay the Company's tax obligations. On August 4, 2017, the underwriters exercised their over-allotment option in full resulting in an additional 4,050,000 Units being issued for $40,500,000, less the underwriters' discount of $1,012,500, netting $39,487,500, which was deposited into the Trust Account. In connection with the underwriters' exercise of their over-allotment option in full, the Company also consummated the sale of an additional 1,012,500 Private Placement Warrants at $1.00 resulting in a total of $310,500,000 held in the Trust Account. On August 7, 2017, the Company announced that the holders of the Company's units may elect to separately trade the Common Stock, warrants and rights underlying the units commencing on August 8, 2017. No fractional warrants will be issued upon separation of the units only whole warrants will trade. Those units that are not separated will continue to trade on the NASDAQ Capital Market under the symbol "WRLSU" and the Common Stock, warrants and rights are expected to trade under the symbols "WRLS," "WRLSW" and "WRLSR", respectively. Transaction costs amounted to $8,646,303, consisting of $7,762,500 of underwriting fees, and $883,803 of other costs. In addition, as of March 31, 2019, $139,265 of cash was held outside of the Trust Account, available for working capital purposes. The Company's management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and Private Placement Warrants (subject to terms and conditions set forth in the certain trust agreement), although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then on deposit in the Trust Account, net of taxes payable (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company's warrants or rights. The Common Stock subject to redemption has been recorded at redemption value and classified as temporary equity upon the completion of the Offering, in accordance with Accounting Standards Codification ("ASC") Topic 480 "Distinguishing Liabilities from Equity." The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, in the case of a stockholder vote, a majority of the outstanding shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission ("SEC"), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or other legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Initial Stockholders (as defined below) have agreed to vote their Founder Shares (as defined in Note 6), and any Public Shares held by them in favor of approving a Business Combination and not to redeem any shares. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. The Company will have until August 1, 2019 to consummate a Business Combination (the "Combination Period"). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders' rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company's board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The Sponsor and other holders of Founder Shares prior to the Initial Public Offering (the "Initial Stockholders") have agreed to (i) waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the consummation of a Business Combination, (ii) to waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to consummate a Business Combination within the Combination Period and (iii) not to propose an amendment to the Company's Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company's obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Combination Period, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. However, the Initial Stockholders will be entitled to liquidating distributions with respect to any Public Shares acquired if the Company fails to consummate a Business Combination and liquidates within the Combination Period. In the event of such distribution, it is possible that the per share value of all the assets available for distribution (including Trust Account assets) will be less than the $10.00 per Unit in the Offering. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company's indemnity of the underwriters of the Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the "Securities Act"). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company's independent auditors), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Liquidity

Liquidity	12 Months Ended
	Mar. 31, 2019
Liquidity [Abstract]
LIQUIDITY	2. LIQUIDITY As of March 31, 2019, the Company had $135,265 in its operating bank accounts, $290,454,757 in cash and marketable securities held in the Trust Account to be used for a Business Combination, to repurchase or convert stock, or to pay corporate taxes in connection therewith and a working capital deficit of $8,278,795. As of March 31, 2019, $6,885,174 of the amount deposited in the Trust Account represented interest income, which is available to pay the Company’s tax obligations. To date, the Company has withdrawn $336,274 of interest from the Trust Account in order to pay the Company’s tax obligations. Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluation of prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting target businesses to acquire, and structuring, negotiating and consummating the Business Combination. On June 8, 2018 the Sponsor loaned the Company $1,000,000 for working capital purposes. On February 11, 2019, the Sponsor advanced the Company an additional $317,628 for working capital purposes. On April 10, 2019 and May 9, 2019, the Sponsor advanced the Company $150,000 and $250,000, respectively, for working capital purposes. Each of these working capital loans is evidenced by a promissory note, and are payable without interest upon consummation of a Business Combination or, at the holder’s discretion, the notes may be converted into warrants (“Warrants”) at a conversion price of $1.00 per Warrant, with a limitation to convert only up to $1.5 million of notes. Each Warrant will contain terms identical to those of the warrants issued in the private placement, entitling the holder thereof to purchase one share of Common Stock at an exercise price of $11.50 per share as more fully described in the prospectus for the IPO dated July 27, 2017. On April 22, 2019, the Company announced that its sponsor, had agreed to contribute as a loan, $0.033 for each share of common stock issued in the initial public offering that was not redeemed in connection with the stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation to extend the date by which it has to consummate a business combination for an additional three months, from May 1, 2019 to August 1, 2019. On April 29, 2019, at the Special Meeting of the Company’s Stockholders, the stockholders approved an amendment to its amended and restated certificate of incorporation to extend the date by which the Company has to consummate a business combination for an additional three months, from May 1, 2019 to August 1, 2019. The amendment was approved with 26,163,835 votes cast in favor of the amendment, 2,020,001 votes cast against the amendment and 422,075 abstentions. In connection with the special meeting and the resulting amendment to our amended and restated certificate of incorporation, 3,831,985 shares of our common stock were redeemed from funds available in the Trust Account, for a redemption amount of approximately $10.33 per share. On May 31, 2019, the Company announced that the Company’s sponsor would reduce its contributions to the trust account established in connection with the Company’s initial public offering (the “Trust Account”). The Company’s sponsor will continue to pay the Trust Account $0.033 per Public Share that has not been redeemed per month, but the total monthly payment will be no greater than $200,000. The Company is currently active in discussion with a target company regarding a potential business combination that is anticipated to require an amount of funding less than the current balance of the Trust Account to consummate the business combination. There can be no assurance that the Company will enter into a business combination agreement with the target company or that this or an other potential business combination will be completed. In connection with the Extension, the Sponsor advanced $1,938,349 in additional contributions to the trust account for the period from April 1, 2019 through June 2, 2019. These loans shall be payable without interest upon consummation of a Business Combination. The Sponsor advanced the Company $150,000 on April 19, 2019 and $250,000 on May 19, 2019 for working capital purposes. These loans shall be payable without interest upon consummation of a Business Combination. Promissory notes payable – related party were $3,222,373 and $0, at March 31, 2019 and 2018, respectively. For the year ended March 31, 2019, $1,864,745 of the proceeds of the funds borrowed were treated as an investment of cash in the Trust Account. In addition, two of the Company’s service providers had agreed to defer the payment of fees owed to them until the consummation of a Business Combination, which amounted to $4,814,028 as of March 31, 2019. Such fees are included in accounts payable and accrued expenses in the accompanying balance sheet at March 31, 2019. Based on the foregoing, the Company believes it will have sufficient cash to meet its needs for the next two months (through August 1, 2019) following the date from when the financial statements are issued. In addition, the Company holds a Commitment Letter from its Chief Executive Officer and managing member of the Sponsor, whereby the managing member of the Sponsor commits to funding any working capital shortfalls through the earlier of an initial business combination or the Company’s liquidation. The loans would be issued as required and each loan would be evidenced by a promissory note, up to an aggregate of $750,000. The loans will be non-interest bearing, unsecured and payable upon the consummation of the Company’s initial business combination or at the holder’s discretion, convertible into warrants of the Company at a price of $1.00 per warrant, up to a maximum of $182,372. If the Company does not complete a business combination, any such loans will be forgiven. The Company may raise additional capital through loans or additional investments from the Sponsor or its stockholders, officers, directors, or third parties. The Company’s officers and directors and the Sponsor may, but, except as described above, are not obligated to, loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. None of the Sponsor, stockholders, officers or directors, or third parties is under any obligation to advance funds to, or invest in, the Company, except for the $750,000 commitment discussed above. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. Even if the Company can obtain sufficient financing or raise additional capital, it only has until August 1, 2019 to consummate a business combination. There is no assurance that the Company will be able to do so prior to August 1, 2019.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the united States of America ("GAAP") and pursuant to the rules and regulations of the SEC. Emerging growth company The Company is an "emerging growth company," as defined in Section 2(a) of the Securities Act of 1933, as amended, (the "Securities Act"), as modified by the Jumpstart our Business Startups Act of 2012, (the "JOBS Act"), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b) (1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company's financial statements with another public company, which is neither an emerging growth company nor an emerging growth company, which has opted out of using the extended transition period, difficult or impossible because of the potential differences in accounting standards used. Use of estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2019 and March 31, 2018. Cash and marketable securities held in Trust Account At March 31, 2019 and March 31, 2018, the assets held in the Trust Account were held in cash and U.S. Treasury Bills and are classified as trading securities. Common stock subject to possible redemption The Company accounts for its Common Stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification ("ASC") Topic 480 "Distinguishing Liabilities from Equity." Common Stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable Common Stock (including Common Stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company's control) is classified as temporary equity. At all other times, common stock is classified as stockholders' equity. The Common Stock features certain redemption rights that are considered to be outside of the Company's control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2019 and March 31, 2018, Common Stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders' equity section of the Company's balance sheets. Income taxes The Company complies with the accounting and reporting requirements of ASC Topic 740 "Income Taxes," which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities. At March 31, 2019, management had determined that it is more likely than not, that its deferred income tax asset, which previously had been reduced by a valuation allowance, will be realized within the next year. The deferred income tax asset of $216,000 arose from tax benefits related to net operating losses not previously utilized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of March 31, 2019 and March 31, 2018, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company may be subject to potential examination by federal, state and city taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal, state and city tax laws. The Company has identified its Federal tax return and its State tax returns in Delaware, Georgia, Louisiana, New York, and North Carolina as "major" tax jurisdictions. The Company's management does not expect that the total amount of unrecognized tax benefits will materially change over the next year. Net loss per common share The Company complies with accounting and disclosure requirements ASC Topic 260, "Earnings Per Share." Net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. Shares of Common Stock subject to possible redemption at March 31, 2019 and March 31, 2018 have been excluded from the calculation of basic income (loss) per share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of (1) warrants sold in the Initial Public Offering and private placement to purchase 15,525,000 and 10,512,500 shares of Common Stock, respectively, (2) rights sold in the Initial Public Offering that convert into 3,105,000 shares of Common Stock, (3) the unit purchase option of 1,350,000 Units sold to the underwriters, exercisable at $10.00 per Unit, which consists of 1,350,000 shares of Common Stock, 675,000 warrants (convertible into 675,000 shares of Common Stock), and 1,350,000 rights (convertible into 135,000 shares of Common Stock) and, 4) the $1,317,628 promissory note, which is payable without interest upon consummation of a Business Combination or, at the holder's discretion, which may be converted into warrants ("Warrants") at a conversion price of $1.00 per Warrant, entitling the holder thereof to purchase one share of Common Stock, par value $0.001, at an exercise price of $11.50 per share, in the calculation of diluted loss per share, since the exercise of the warrants, the conversion of the rights into shares of Common Stock and conversion of the working capital loan are contingent upon the occurrence of a future event. As a result, diluted loss per common share is the same as basic loss per common share for the periods. Reconciliation of net loss per common share The Company's net income is adjusted for the portion of income that is attributable to Common Stock subject to redemption, as these shares only participate in the income of the Trust Account and not the losses of the Company. Accordingly, basic and diluted loss per common share is calculated as follows: For the Year Ended For the Year Ended Net income (loss) $ 989,799 $ (2,520,045 ) Less: Income attributable to common shares subject to redemption (a) (4,841,402 ) (1,386,915 ) Adjusted loss $ (3,851,603 ) $ (3,906,960 ) Weighted average shares outstanding, basic and diluted 8,563,373 6,790,097 Basic and diluted net loss per common share $ (0.45 ) $ (0.58 ) (a) Interest Income $ 5,281,923 $ 1,603,251 Less: Income Taxes* 163 31,425 Less: Franchise Taxes 212,569 152,573 5,069,191 1,419,253 Percentage of common shares subject to redemption to total common shares 95.51 % 97.72 % Income attributable to common shares subject to redemption $ 4,841,402 $ 1,386,915 * Excludes any benefit derived from deferred income tax asset. Concentration of credit risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At March 31, 2019 and March 31, 2018, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair value of financial instruments The fair value of the Company's assets and liabilities, which qualify as financial instruments under ASC Topic 820, "Fair Value Measurements and Disclosures," approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature. Recently issued accounting pronouncements Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company's consolidated financial statements.

Initial Public Offering

Initial Public Offering	12 Months Ended
	Mar. 31, 2019
Equity [Abstract]
INITIAL PUBLIC OFFERING	4. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering the Company sold 27,000,000 units at a purchase price of $10.00 per Unit. Each Unit consists of one share of Common Stock, par value of $0.001 of the Company ("Common Stock"), one right ("Public Right") and one-half of one redeemable warrant ("Public Warrant"). Each Public Right will convert into one-tenth (1/10) of one share of Common Stock upon consummation of a Business Combination (see Note 8). Each whole Public Warrant entitles the holder to purchase one share of Common Stock at an exercise price of $11.50 (see Note 8). On August 4, 2017, the over-allotment option was exercised in full and the underwriters purchased 4,050,000 additional Units at $10.00 per Unit, generating gross proceeds of $40,500,000. Proceeds of $310,500,000 from the Initial Public Offering and Private Placement Warrants are held in the trust account, along with any additional interest earned thereon not used to pay for taxes.

Private Placement

Private Placement	12 Months Ended
	Mar. 31, 2019
Equity [Abstract]
PRIVATE PLACEMENT	5. PRIVATE PLACEMENT Simultaneously with the Initial Public Offering, the Sponsor, MasTec and EBC purchased 9,500,000 Private Placement Warrants at $1.00 per warrant in a private placement generating gross proceeds of $9,500,000. Simultaneously with the sale of the over-allotment Units, the Company consummated the sale of an additional 1,012,500 warrants at $1.00 per warrant, generating gross proceeds of $1,012,500. The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds of the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. The Private Placement Warrants are identical to the Warrants sold in the Offering except that the Private Placement Warrants (i) will not be redeemable by the Company and (ii) may be exercised for cash or on a cashless basis, so long as they are held by the initial purchaser or any of its permitted transferees. In addition, the Private Placement Warrants and their component securities may not be transferable, assignable or salable until 30 days after the consummation of a Business Combination, subject to certain limited exceptions.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Mar. 31, 2019
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	6. RELATED PARTY TRANSACTIONS Founder Shares In May 2016, the Company issued 10,000 shares of Common Stock to the Sponsor for $10. In May 2017, the Company issued an additional 7,177,500 shares of Common Stock to the Sponsor and certain other persons (collectively, the "Founder Shares") for an aggregate purchase price of $24,990, or approximately $0.0035 per share. In June 2017, the Sponsor transferred 1,575,000 of such shares to MasTec for the same purchase price originally paid for such shares. In July 2017, the company effected a stock dividend with respect to the Common Stock of 575,000 shares, resulting in the Initial Stockholders holding an aggregate of 7,762,500 shares. All share and per share, amounts have been retroactively restated to reflect the stock dividend. The Founder Shares included an aggregate of up to 1,012,500 shares that were subject to forfeiture by the Initial Stockholders to the extent that the underwriters' over-allotment was not exercised in full or in part, so that the Initial Stockholders would own, on an as-converted basis, 20% of the Company's issued and outstanding shares after the Offering. As a result of the underwriters' election to exercise their over-allotment option in full on August 4, 2017, 1,012,500 Founder shares are no longer subject to forfeiture. The Initial Stockholders have agreed that, subject to certain limited exceptions, the Founder Shares will not be transferred, assigned or sold until one year after the date of the consummation of a Business Combination or earlier if, subsequent to a Business Combination, the last sales price of the Company's Common Stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period. Related Party Loans On June 8, 2018, the Sponsor advanced the Company $1,000,000 for working capital purposes. On February 11, 2019, the Sponsor advanced the Company an additional $317,628 for working capital purposes. On April 10, 2019 and May 9, 2019, the Sponsor advanced the Company $150,000 and $250,000, respectively, for working capital purposes. The Working Capital Loans, evidenced by a promissory note, are payable without interest upon consummation of a Business Combination or, at the holder's discretion, up to $1,500,000 of the notes may be converted into warrants ("Warrants") at a conversion price of $1.00 per Warrant. Each Warrant will contain terms identical to those of the warrants issued in the private placement, entitling the holder thereof to purchase one share of Common Stock at an exercise price of $11.50 per share as more fully described in the prospectus for the IPO dated July 27, 2017. In order to finance transaction costs in connection with a Business Combination, the Sponsor, the Company's officers and directors may, but are not obligated to, loan the Company funds from time to time or at any time, as may be required ("Working Capital Loans"). Each Working Capital Loan would be evidenced by a promissory note. The Working Capital Loans would either be paid upon consummation of a Business Combination, without interest, or, at the holder's discretion, up to $1,500,000 of the Working Capital Loans may be converted into Warrants at a price of $1.00 per Warrant. The Warrants would be identical to the Private Placement Warrants. The Company received a Commitment Letter from the managing member of the Sponsor, Pensare Sponsor Group, LLC ("PSG"), whereby the managing member of PSG commits to funding any working capital shortfalls through the earlier of an initial business combination or the Company's liquidation. The loans would be issued as required and a promissory note, up to an aggregate of Seven Hundred and Fifty Thousand Dollars ($750,000), would evidence each loan. The loans will be non-interest bearing, unsecured and payable upon the consummation of the Company's initial business combination or at the holder's discretion, up to $500,000 of the commitment may be convertible into warrants of the Company at a price of $1.00 per warrant. If the Company does not complete a business combination, any such loans will be forgiven. As of March 31, 2019, the Company had no promissory notes outstanding related to this commitment. On January 16, 2019, the Company announced that the Sponsor had agreed to contribute to the Company as a loan $0.033 for each public share that was not redeemed in connection with the stockholder vote to approve an amendment to the Company's amended and restated certificate of incorporation to extend the date by which the Company has to consummate a business combination for an additional three months, from February 1, 2019 to May 1, 2019, for each calendar month (commencing on February 2, 2019 and on the second day of each subsequent month), or portion thereof, that is needed by the Company to complete a Business Combination from February 2, 2019 until May 1, 2019. On February 1, 2019, the Company signed a promissory note agreeing to pay up to $2,797,117 of advances to be made by the Sponsor to cover contribution payments due to the Trust Account. On April 29, 2019, the Company held a special meeting of stockholders at which time the stockholders of the Company approved an amendment to the Company's amended and restated certificate of incorporation to extend the date by which the Company has to consummate a business combination for an additional three months, from May 1, 2019 to August 1, 2019. On April 22, 2019, the Company announced that the Sponsor, had agreed to contribute as a loan, $0.033 for each share of common stock issued in the initial public offering that was not redeemed in connection with the stockholder vote to approve an amendment to the Company's amended and restated certificate of incorporation to extend the date by which they have to consummate a business combination for an additional three months, from May 1, 2019 to August 1, 2019. The contribution was deposited in the trust account established in connection with the Company's initial public offering. On May 9, 2019, the Company signed a promissory note agreeing to repay $805,916 for an advance made by the Sponsor as an additional contribution payment to the Trust Account. On May 31, 2019, the Company announced that the Sponsor will reduce its contributions to the Trust Account. The Sponsor will continue to pay to the Trust Account $0.033 per public share that has not been redeemed per month, but the total monthly payment will be no greater than $200,000. If more than 6,060,606 public shares remain outstanding after redemptions in connection with this adjustment, then the amount paid per share will be reduced proportionately. In connection with this announcement, the Company offered the public stockholders the right to redeem their shares of common stock for their pro rata portion of the funds available in the Trust Account. Promissory notes payable – related party were $3,222,373 and $0, at March 31, 2019 and 2018, respectively. Related Party Fees The Company has incurred related party administrative fees of $20,000 per month beginning August 2017. These costs have been included in the operating costs in the company's statements of operations. The administrative fees incurred and paid by the Company were $240,000 and $160,000 for the years ending March 31, 2019 and 2018, respectively.

Commitments

Commitments	12 Months Ended
	Mar. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS	7. COMMITMENTS Registration Rights The holders of the Founder Shares, Private Placement Warrants (and their underlying securities) and any warrants that may be issued upon conversion of the Working Capital Loans (and their underlying securities) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Initial Public Offering. The holders of a majority of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders will have certain "piggy-back" registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement will provide that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Business Combination Marketing Agreement The Company has engaged EBC as an advisor in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss a potential Business Combination and the target business' attributes, introduce the Company to potential investors that are interested in purchasing securities, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with a Business Combination. The Company will pay EBC a cash fee for such services upon the consummation of an initial Business Combination in an amount equal to 3.5% of the gross proceeds of the offering (exclusive of any applicable finders' fees which might become payable); provided that the Company has the right to allocate up to 30% of the fee to any of the underwriters in the offering or other FINRA member firms the Company retains to assist it in connection with its initial Business Combination.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Mar. 31, 2019
Equity [Abstract]
STOCKHOLDERS' EQUITY	8. STOCKHOLDERS' EQUITY Preferred Stock Common Stock Rights If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of rights will not receive any of such funds with respect to their rights, nor will they receive any distribution from the Company's assets held outside of the Trust Account with respect to such rights, and the rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the rights upon consummation of a Business Combination. Additionally, in no event will the Company be required to net cash settle the rights. Warrants The Private Placement Warrants are identical to the Public Warrants underlying the Units being sold in the Offering, except that the Private Placement Warrants and the Common Stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. The Company may redeem the Public Warrants (except with respect to the Placement Warrants): ● in whole and not in part; ● at a price of $0.01 per warrant; ● at any time during the exercise period; ● upon a minimum of 30 days' prior written notice of redemption; ● if, and only if, the last sale price of the Company's Common Stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; and ● if, and only if, there is a current registration statement in effect with respect to the shares of Common Stock underlying such warrants. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a "cashless basis," as described in the warrant agreement. The exercise price and number of shares of Common Stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Common Stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company's assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. Unit Purchase Options The Company estimated that the fair value of this unit purchase option was approximately $4,547,505 (or $3.37 per Unit) using a Black-Scholes option-pricing model. The fair value of the unit purchase option granted to the underwriters was estimated as of the date of grant using the following assumptions: (1) expected volatility of 35%, (2) risk-free interest rate of 1.80% and (3) expected life of five years. The option and the 1,350,000 Units have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(g)(1) of FINRA's NASDAQ Conduct Rules. Additionally, the option may not be sold, transferred, assigned, pledged or hypothecated for a one-year period (including the foregoing 180-day period) following the date of Offering except to any underwriter and selected dealer participating in the Offering and their bona fide officers or partners. The option grants to holders demand and "piggy back" rights for periods of five and seven years, respectively, from the effective date of the registration statement with respect to the registration under the Securities Act of the securities directly and indirectly issuable upon exercise of the option. The Company will bear all fees and expenses attendant to registering the securities, other than underwriting commissions, which will be paid for by the holders themselves. The exercise price and number of units issuable upon exercise of the option may be adjusted in certain circumstances including in the event of a stock dividend, or the Company's recapitalization, reorganization, merger or consolidation. However, the option will not be adjusted for issuances of Common Stock at a price below its exercise price.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Mar. 31, 2019
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	9. FAIR VALUE MEASUREMENTS The Company follows guidance in ASC 820 for its financial assets and liabilities that are re-measured at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company's financial assets and liabilities reflects management's estimate of amounts that the Company would have received in connection with the sale of the assets paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company's assets that are measured at fair value on a recurring basis at December 31, 2018 and March 31, 2018, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level March 31, 2019 March 31, 2018 Assets: Cash and marketable securities held in Trust Account 1 $ 290,454,757 $ 312,103,251

Income Tax

Income Tax	12 Months Ended
	Mar. 31, 2019
Income Tax Disclosure [Abstract]
INCOME TAX	10. INCOME TAX On December 31, 2017, the U.S. Tax Cuts and Job Acts of 2017 (“Tax Reform”) was signed into law. As a result of Tax Reform, the U.S. statutory tax rate was lowered from 35% to 21% effective January 1, 2018, among other changes. ASC Topic 740 requires companies to recognize the effect of tax law changes in the period of enactment; therefore, the Company would be required to revalue its deferred tax assets and liabilities at December 31, 2017 at the new rate. The SEC issued Staff Accounting Bulletin No. 118 (SAB 118”) to address the application of GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain tax effects of Tax Reform. The financial statement impact related to the adoption of Tax Act 2017 had no impact on the total provision for income tax expense (benefit) for the year ending March 31, 2018 and 2017. The Company’s net deferred tax assets are as follows: Year Ended March 31, 2019 Year Ended March 31, 2018 Deferred tax asset Net operating loss carryforward $ 378,831 $ 543,458 Total deferred tax assets 378,831 543,458 Valuation allowance (162,831 ) (543,458 ) Deferred tax asset, net of allowance $ 216,000 $ - The income tax benefit (provision) consist of the following: Year Ended March 31, 2019 Year Ended March 31, 2018 Federal Current $ - $ - Deferred (164,627 ) 543,458 State Current $ (163 ) $ (183,998 ) Deferred - - Change in valuation allowance 380,627 (543,458 ) Income tax benefit (provision) $ 215,837 $ (183,998 ) A reconciliation of federal income tax rate to the Company’s effective tax rate at March 31, 2019 is as follows: Year Ended March 31, 2019 Year Ended March 31, 2018 Statutory federal income tax rate 21.00 % 0.0 % State taxes, net of federal tax benefit 0.02 % 0.0 % Permanent items 0.27 % 0.0 % Change in valuation allowance (49.18 )% 0.0 % State Franchise taxes 0.00 % 7.88 % Income tax provision (benefit) (27.89 )% 7.88 % As of March 31, 2019, the Company has a federal net operating loss carryforward of approximately $1,804,000, which expires in year 2038. Upon confirmation of an ownership change, the net operating loss would be reduced and any remaining net operating loss utilization would be subject to an annual limitation under Section 382 of the Internal Revenue Code. A valuation allowance has been established to offset the net deferred tax asset to the extent the Company has determined that it is more likely than not that the future tax benefits will be realized. The Company files a federal income tax return and separate income tax returns in various states. For federal and certain states, the 2016 through 2018 tax years remain open for examination by the tax authorities under the normal three-year statute of limitations.

Subsequent Events

Subsequent Events	12 Months Ended
	Mar. 31, 2019
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	11. SUBSEQUENT EVENT The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements were issued. Except as follows, the Company did not identify subsequent events that would have required adjustment or disclosure in the financial statements other than the following. On April 22, 2019, the Company announced that its sponsor, had agreed to contribute as a loan, $0.033 for each share of common stock issued in the initial public offering that was not redeemed in connection with the stockholder vote to approve an amendment to the Company's amended and restated certificate of incorporation to extend the date by which it has to consummate a business combination for an additional three months, from May 1, 2019 to August 1, 2019. On April 29, 2019, at the Special Meeting of the Company's Stockholders, the stockholders approved an amendment to its amended and restated certificate of incorporation to extend the date by which the Company has to consummate a business combination for an additional three months, from May 1, 2019 to August 1, 2019. The amendment was approved with 26,163,835 votes cast in favor of the amendment, 2,020,001 votes cast against the amendment and 422,075 abstentions. In connection with the special meeting and the resulting amendment to our amended and restated certificate of incorporation, 3,831,985 shares of our common stock were redeemed from funds available in the Trust Account, for a redemption amount of approximately $10.33 per share. On May 31, 2019, the Company announced that the Company's sponsor would reduce its contributions to the trust account established in connection with the Company's initial public offering (the "Trust Account"). The Company's sponsor will continue to pay the Trust Account $0.033 per Public Share that has not been redeemed per month, but the total monthly payment will be no greater than $200,000. The Company is currently active in discussion with a target company regarding a potential business combination that is anticipated to require an amount of funding less than the current balance of the Trust Account to consummate the business combination. There can be no assurance that the Company will enter into a business combination agreement with the target company or that this or an other potential business combination will be completed. In connection with the Extension, the Sponsor advanced $1,938,349 in additional contributions to the trust account for the period from April 1, 2019 through June 2, 2019. These loans shall be payable without interest upon consummation of a Business Combination. The Sponsor advanced the Company $150,000 on April 19, 2019 and $250,000 on May 19, 2019 for working capital purposes. These loans shall be payable without interest upon consummation of a Business Combination.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the united States of America ("GAAP") and pursuant to the rules and regulations of the SEC.
Emerging growth company	Emerging growth company The Company is an "emerging growth company," as defined in Section 2(a) of the Securities Act of 1933, as amended, (the "Securities Act"), as modified by the Jumpstart our Business Startups Act of 2012, (the "JOBS Act"), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b) (1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company's financial statements with another public company, which is neither an emerging growth company nor an emerging growth company, which has opted out of using the extended transition period, difficult or impossible because of the potential differences in accounting standards used.
Use of estimates	Use of estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and cash equivalents	Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2019 and March 31, 2018.
Cash and marketable securities held in Trust Account	Cash and marketable securities held in Trust Account At March 31, 2019 and March 31, 2018, the assets held in the Trust Account were held in cash and U.S. Treasury Bills and are classified as trading securities.
Common stock subject to possible redemption	Common stock subject to possible redemption The Company accounts for its Common Stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification ("ASC") Topic 480 "Distinguishing Liabilities from Equity." Common Stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable Common Stock (including Common Stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company's control) is classified as temporary equity. At all other times, common stock is classified as stockholders' equity. The Common Stock features certain redemption rights that are considered to be outside of the Company's control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2019 and March 31, 2018, Common Stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders' equity section of the Company's balance sheets.
Income taxes	Income taxes The Company complies with the accounting and reporting requirements of ASC Topic 740 "Income Taxes," which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities. At March 31, 2019, management had determined that it is more likely than not, that its deferred income tax asset, which previously had been reduced by a valuation allowance, will be realized within the next year. The deferred income tax asset of $216,000 arose from tax benefits related to net operating losses not previously utilized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of March 31, 2019 and March 31, 2018, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company may be subject to potential examination by federal, state and city taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal, state and city tax laws. The Company has identified its Federal tax return and its State tax returns in Delaware, Georgia, Louisiana, New York, and North Carolina as "major" tax jurisdictions. The Company's management does not expect that the total amount of unrecognized tax benefits will materially change over the next year.
Net loss per common share	Net loss per common share The Company complies with accounting and disclosure requirements ASC Topic 260, "Earnings Per Share." Net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. Shares of Common Stock subject to possible redemption at March 31, 2019 and March 31, 2018 have been excluded from the calculation of basic income (loss) per share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of (1) warrants sold in the Initial Public Offering and private placement to purchase 15,525,000 and 10,512,500 shares of Common Stock, respectively, (2) rights sold in the Initial Public Offering that convert into 3,105,000 shares of Common Stock, (3) the unit purchase option of 1,350,000 Units sold to the underwriters, exercisable at $10.00 per Unit, which consists of 1,350,000 shares of Common Stock, 675,000 warrants (convertible into 675,000 shares of Common Stock), and 1,350,000 rights (convertible into 135,000 shares of Common Stock) and, 4) the $1,317,628 promissory note, which is payable without interest upon consummation of a Business Combination or, at the holder's discretion, which may be converted into warrants ("Warrants") at a conversion price of $1.00 per Warrant, entitling the holder thereof to purchase one share of Common Stock, par value $0.001, at an exercise price of $11.50 per share, in the calculation of diluted loss per share, since the exercise of the warrants, the conversion of the rights into shares of Common Stock and conversion of the working capital loan are contingent upon the occurrence of a future event. As a result, diluted loss per common share is the same as basic loss per common share for the periods.
Reconciliation of net loss per common share	Reconciliation of net loss per common share The Company's net income is adjusted for the portion of income that is attributable to Common Stock subject to redemption, as these shares only participate in the income of the Trust Account and not the losses of the Company. Accordingly, basic and diluted loss per common share is calculated as follows: For the Year Ended For the Year Ended Net income (loss) $ 989,799 $ (2,520,045 ) Less: Income attributable to common shares subject to redemption (a) (4,841,402 ) (1,386,915 ) Adjusted loss $ (3,851,603 ) $ (3,906,960 ) Weighted average shares outstanding, basic and diluted 8,563,373 6,790,097 Basic and diluted net loss per common share $ (0.45 ) $ (0.58 ) (a) Interest Income $ 5,281,923 $ 1,603,251 Less: Income Taxes* 163 31,425 Less: Franchise Taxes 212,569 152,573 5,069,191 1,419,253 Percentage of common shares subject to redemption to total common shares 95.51 % 97.72 % Income attributable to common shares subject to redemption $ 4,841,402 $ 1,386,915 * Excludes any benefit derived from deferred income tax asset.
Concentration of credit risk	Concentration of credit risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At March 31, 2019 and March 31, 2018, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair value of financial instruments	Fair value of financial instruments The fair value of the Company's assets and liabilities, which qualify as financial instruments under ASC Topic 820, "Fair Value Measurements and Disclosures," approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature.
Recently issued accounting pronouncements	Recently issued accounting pronouncements Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company's consolidated financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
Schedule for reconciliation of net loss per common share	For the Year Ended For the Year Ended Net income (loss) $ 989,799 $ (2,520,045 ) Less: Income attributable to common shares subject to redemption (a) (4,841,402 ) (1,386,915 ) Adjusted loss $ (3,851,603 ) $ (3,906,960 ) Weighted average shares outstanding, basic and diluted 8,563,373 6,790,097 Basic and diluted net loss per common share $ (0.45 ) $ (0.58 ) (a) Interest Income $ 5,281,923 $ 1,603,251 Less: Income Taxes* 163 31,425 Less: Franchise Taxes 212,569 152,573 5,069,191 1,419,253 Percentage of common shares subject to redemption to total common shares 95.51 % 97.72 % Income attributable to common shares subject to redemption $ 4,841,402 $ 1,386,915 * Excludes any benefit derived from deferred income tax asset.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Mar. 31, 2019
Fair Value Disclosures [Abstract]
Schedule of fair value hierarchy of valuation inputs	Description Level March 31, 2019 March 31, 2018 Assets: Cash and marketable securities held in Trust Account 1 $ 290,454,757 $ 312,103,251

Income Tax (Tables)

Income Tax (Tables)	12 Months Ended
	Mar. 31, 2019
Income Tax Disclosure [Abstract]
Schedule of deferred tax assets	Year Ended March 31, 2019 Year Ended March 31, 2018 Deferred tax asset Net operating loss carryforward $ 378,831 $ 543,458 Total deferred tax assets 378,831 543,458 Valuation allowance (162,831 ) (543,458 ) Deferred tax asset, net of allowance $ 216,000 $ -
Schedule of income tax benefit (provision)	Year Ended March 31, 2019 Year Ended March 31, 2018 Federal Current $ - $ - Deferred (164,627 ) 543,458 State Current $ (163 ) $ (183,998 ) Deferred - - Change in valuation allowance 380,627 (543,458 ) Income tax benefit (provision) $ 215,837 $ (183,998 )
Schedule of reconciliation of effective tax rate	Year Ended March 31, 2019 Year Ended March 31, 2018 Statutory federal income tax rate 21.00 % 0.0 % State taxes, net of federal tax benefit 0.02 % 0.0 % Permanent items 0.27 % 0.0 % Change in valuation allowance (49.18 )% 0.0 % State Franchise taxes 0.00 % 7.88 % Income tax provision (benefit) (27.89 )% 7.88 %

Description of Organization a_2

Description of Organization and Business Operations (Details) - USD ($)	Aug. 04, 2017	Aug. 01, 2017	Apr. 29, 2019	Jan. 28, 2019	Mar. 31, 2019	Apr. 22, 2019	Mar. 31, 2018
Description of Organization and Business Operations (Textual)
Common stock, par value					$ 0.001		$ 0.001
Payment to trust account price per share					$ 0.033
Public shares remain outstanding connection with adjustment					6,060,606
Warrant price per share					$ 1
Cash held outside of trust account					$ 62,725		$ 183,998
Trust Account [Member]
Description of Organization and Business Operations (Textual)
Description of redemption settlement terms				The amendment was approved with 26,352,896 votes cast in favor of the amendment, 122,986 votes cast against the amendment and 323,175 abstentions. In connection with the special meeting and the resulting amendment to our amended and restated certificate of incorporation, 2,796,290 shares of our common stock were redeemed from funds available in the trust account established in connection with the Company’s initial public offering (the “Trust Account”), for a redemption amount of approximately $10.18 per share.
Subsequent Event [Member] | Trust Account [Member]
Description of Organization and Business Operations (Textual)
Description of redemption settlement terms			The amendment was approved with 26,163,835 votes cast in favor of the amendment, 2,020,001 votes cast against the amendment and 422,075 abstentions. In connection with the special meeting and the resulting amendment to our amended and restated certificate of incorporation, 3,831,985 shares of our common stock were redeemed from funds available in the Trust Account, for a redemption amount of approximately $10.33 per share.
Initial Public Offering [Member] | Trust Account [Member]
Description of Organization and Business Operations (Textual)
Cash held outside of trust account					$ 139,265
Description of redemption settlement terms					The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then on deposit in the Trust Account, net of taxes payable (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants or rights. The Common Stock subject to redemption has been recorded at redemption value and classified as temporary equity upon the completion of the Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, in the case of a stockholder vote, a majority of the outstanding shares voted are voted in favor of the Business Combination.
Initial Public Offering [Member] | Common Stock [Member]
Description of Organization and Business Operations (Textual)
Number of shares issued		27,000,000
Common stock, par value		$ 0.001
Price per share		$ 10
Gross proceeds		$ 270,000,000
Initial Public Offering [Member] | Subsequent Event [Member]
Description of Organization and Business Operations (Textual)
Price per share						$ 0.033
Private Placement Warrants [Member]
Description of Organization and Business Operations (Textual)
Number of shares issued	1,012,500
Price per share	$ 1
Gross proceeds	$ 1,012,500
Transaction costs					$ 8,646,303
Underwriting fees					7,762,500
Other costs					$ 883,803
Private Placement Warrants [Member] | Pensare Sponsor Group LLC (the "Sponsor") [Member] | MasTec, Inc. ("MasTec") [Member] | Early Bird Capital, Inc. ("EBC") [Member]
Description of Organization and Business Operations (Textual)
Number of shares issued		9,500,000
Gross proceeds		$ 9,500,000
Warrant price per share		$ 1
Private Placement Warrants [Member] | Trust Account [Member]
Description of Organization and Business Operations (Textual)
Held in trust account	$ 310,500,000
Over-Allotment Option [Member]
Description of Organization and Business Operations (Textual)
Warrant price per share					$ 10
Over-Allotment Option [Member] | Underwriter [Member]
Description of Organization and Business Operations (Textual)
Number of shares issued	4,050,000
Price per share	$ 10
Gross proceeds	$ 40,500,000
Underwriter deferred discount	1,012,500
Net proceeds from units issued	$ 39,487,500

Liquidity (Details)

Liquidity (Details) - USD ($)

May 09, 2019

Apr. 10, 2019

Feb. 11, 2019

Jun. 08, 2018

May 19, 2019

Apr. 29, 2019

Apr. 22, 2019

Apr. 19, 2019

Jan. 28, 2019

Jun. 02, 2019

Mar. 31, 2019

Mar. 31, 2018

Mar. 31, 2017

Transaction costs

Operating bank accounts

$ 135,265

$ 482,676

$ 8,562

Working capital deficit

8,278,795

Interest earned on marketable securities held in Trust Account

5,281,923

$ 1,603,251

Principal amount

$ 750,000

Warrant exercise price (in dollars per share)

$ 1

Fair value of warrant

$ 182,372

Common stock, par value (in dollars per share)

$ 0.001

$ 0.001

Interest from Trust Account

$ 336,274

Payment of fees owed to Business Combination

4,814,028

Deposited trust account

6,885,174

Withdrawal from Trust Account for taxes

336,274

Promissory notes payable - related party

$ 3,222,373

Share price

$ 0.033

Investment of cash in trust account

$ 1,864,745

310,500,000

Subsequent Event [Member]

Transaction costs

Sponsor advanced

$ 250,000

$ 150,000

Subsequent Event [Member] | Initial Public Offering [Member]

Transaction costs

Share of common stock issued

$ 0.033

Trust Account [Member]

Transaction costs

Description of redemption settlement terms

The amendment was approved with 26,352,896 votes cast in favor of the amendment, 122,986 votes cast against the amendment and 323,175 abstentions. In connection with the special meeting and the resulting amendment to our amended and restated certificate of incorporation, 2,796,290 shares of our common stock were redeemed from funds available in the trust account established in connection with the Company’s initial public offering (the “Trust Account”), for a redemption amount of approximately $10.18 per share.

Trust Account [Member] | Initial Public Offering [Member]

Transaction costs

Description of redemption settlement terms

The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then on deposit in the Trust Account, net of taxes payable (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants or rights. The Common Stock subject to redemption has been recorded at redemption value and classified as temporary equity upon the completion of the Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, in the case of a stockholder vote, a majority of the outstanding shares voted are voted in favor of the Business Combination.

Trust Account [Member] | Subsequent Event [Member]

Transaction costs

Sponsor advanced

$ 1,938,349

Description of redemption settlement terms

The amendment was approved with 26,163,835 votes cast in favor of the amendment, 2,020,001 votes cast against the amendment and 422,075 abstentions. In connection with the special meeting and the resulting amendment to our amended and restated certificate of incorporation, 3,831,985 shares of our common stock were redeemed from funds available in the Trust Account, for a redemption amount of approximately $10.33 per share.

Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]

Transaction costs

Cash and marketable securities held in Trust Account

$ 290,454,757

$ 312,103,251

Warrant [Member]

Transaction costs

Warrant exercise price (in dollars per share)

$ 11.50

Sponsor [Member]

Transaction costs

Working capital purposes

$ 250,000

$ 150,000

$ 1,000,000

Promissory Note [Member] | Warrant [Member]

Transaction costs

Warrant exercise price (in dollars per share)

$ 11.50

Debt conversion price (in dollars per share)

1

Common stock, par value (in dollars per share)

$ 0.001

Promissory Note [Member] | Sponsor [Member]

Transaction costs

Debt interest rate terms

Payable without interest upon consummation of a Business Combination or, at the holder.

Working capital purposes

$ 317,628

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - USD ($)		12 Months Ended
		Mar. 31, 2019	Mar. 31, 2018
Accounting Policies [Abstract]
Net income (loss)		$ 989,799	$ (2,520,045)
Less: Income attributable to common shares subject to redemption		(4,841,402)	(1,386,915)
Adjusted loss		$ (3,851,603)	$ (3,906,960)
Weighted average shares outstanding, basic and diluted		8,563,373	6,790,097
Basic and diluted net loss per common share		$ (0.45)	$ (0.58)
Interest Income		$ 5,281,923	$ 1,603,251
Less: Income Taxes	[1]	163	31,425
Less: Franchise Taxes		212,569	152,573
Interest income net of tax		$ 5,069,191	$ 1,419,253
Percentage of common shares subject to redemption to total common shares		95.51%	97.72%
Income attributable to common shares subject to redemption		$ 4,841,402	$ 1,386,915
[1]	Excludes any benefit derived from deferred income tax asset

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details Textual) - USD ($)	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Summary of Significant Accounting Policies (Textual)
Federal corporate tax rate	21.00%	0.00%
Description of share conversion	(1) warrants sold in the Initial Public Offering and private placement to purchase 15,525,000 and 10,512,500 shares of Common Stock, respectively, (2) rights sold in the Initial Public Offering that convert into 3,105,000 shares of Common Stock, (3) the unit purchase option of 1,350,000 Units sold to the underwriters, exercisable at $10.00 per Unit, which consists of 1,350,000 shares of Common Stock, 675,000 warrants (convertible into 675,000 shares of Common Stock), and 1,350,000 rights (convertible into 135,000 shares of Common Stock) and, 4) the $1,317,628 promissory note, which is payable without interest upon consummation of a Business Combination or, at the holder's discretion, which may be converted into warrants ("Warrants") at a conversion price of $1.00 per Warrant, entitling the holder thereof to purchase one share of Common Stock, par value $0.001, at an exercise price of $11.50 per share, in the calculation of diluted loss per share, since the exercise of the warrants, the conversion of the rights into shares of Common Stock and conversion of the working capital loan are contingent upon the occurrence of a future event.
Federal depository insurance coverage	$ 250,000
Deferred income tax asset	$ 216,000

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($)	Aug. 04, 2017	Aug. 01, 2017	Mar. 31, 2019	Mar. 31, 2018
Subsidiary, Sale of Stock [Line Items]
Warrant exercise price (in dollars per share)			$ 1
Common stock, par value			0.001	$ 0.001
Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Warrant exercise price (in dollars per share)			11.50
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Warrant exercise price (in dollars per share)			$ 10
Over-Allotment Option [Member] | Underwriter [Member]
Subsidiary, Sale of Stock [Line Items]
Number of unit issued	4,050,000
Units (in dollars per share)	$ 10
Gross proceeds from units issued	$ 40,500,000
Private Placement Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of unit issued	1,012,500
Units (in dollars per share)	$ 1
Gross proceeds from units issued	$ 1,012,500
Private Placement Warrants [Member] | Trust Account [Member]
Subsidiary, Sale of Stock [Line Items]
Trust account balance	$ 310,500,000
Initial Public Offering [Member] | Public Rights [Member]
Subsidiary, Sale of Stock [Line Items]
Description of number of shares consisted in each unit			1/10
Warrant exercise price (in dollars per share)			$ 11.50
Initial Public Offering [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Number of unit issued		27,000,000
Units (in dollars per share)		$ 10
Description of number of shares consisted in each unit		1
Gross proceeds from units issued		$ 270,000,000
Common stock, par value		$ 0.001

Private Placement (Details)

Private Placement (Details) - USD ($)	Aug. 04, 2017	Aug. 01, 2017	Mar. 31, 2019
Subsidiary, Sale of Stock [Line Items]
Warrant exercise price (in dollars per share)			$ 1
Private Placement Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of unit issued	1,012,500
Units (in dollars per share)	$ 1
Gross proceeds from units issued	$ 1,012,500
Private Placement Warrants [Member] | Pensare Sponsor Group LLC (the "Sponsor") [Member] | MasTec, Inc. ("MasTec") [Member] | Early Bird Capital, Inc. ("EBC") [Member]
Subsidiary, Sale of Stock [Line Items]
Warrant exercise price (in dollars per share)		$ 1
Number of unit issued		9,500,000
Gross proceeds from units issued		$ 9,500,000

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)

May 09, 2019

Apr. 10, 2019

Feb. 11, 2019

Jun. 08, 2018

Aug. 04, 2017

Jul. 02, 2017

May 31, 2019

May 31, 2019

Jul. 31, 2017

Jun. 30, 2017

May 31, 2017

May 31, 2016

Mar. 31, 2019

Mar. 31, 2018

Related Party Transactions (Textual)

Purchase price

$ 24,990

Share price (in dollars per share)

$ 0.033

Number of shares subject to forfeiture

1,012,500

Principal amount

$ 750,000

Description of working loans terms

Each Working Capital Loan would be evidenced by a promissory note. The Working Capital Loans would either be paid upon consummation of a Business Combination, without interest, or, at the holder’s discretion, up to $1,500,000 of the Working Capital Loans may be converted into Warrants at a price of $1.00 per Warrant.

Prepaid expenses

$ 10,398

76,360

Warrant exercise price (in dollars per share)

$ 1

Convertible promissory notes - related parties

$ 3,222,373

Common Stock [Member]

Related Party Transactions (Textual)

Number of additional shares issued

7,751,700

Purchase price

$ 7,752

Maximum number of shares redeemed

562,123

(30,342,514)

Warrant [Member]

Related Party Transactions (Textual)

Warrant exercise price (in dollars per share)

$ 11.50

Pensare Sponsor Group LLC (the "Sponsor") [Member] | Common Stock [Member]

Related Party Transactions (Textual)

Number of shares issued

10,000

Value of shares issued

$ 10

Founder Shares [Member]

Related Party Transactions (Textual)

Maximum number of shares redeemed

1,012,500

Founder Shares [Member] | Pensare Sponsor Group LLC (the "Sponsor") [Member] | Common Stock [Member]

Related Party Transactions (Textual)

Number of additional shares issued

7,177,500

Purchase price

$ 24,990

Share price (in dollars per share)

$ 0.0035

Early Bird Capital, Inc. ("EBC") [Member]

Related Party Transactions (Textual)

Description of cash fees

The consummation of an initial Business Combination in an amount equal to 3.5% of the gross proceeds of the offering (exclusive of any applicable finders’ fees which might become payable); provided that the Company has the right to allocate up to 30% of the fee to any of the underwriters in the offering or other FINRA member firms the Company retains to assist it in connection with its initial Business Combination.

Promissory Note [Member] | Warrant [Member]

Related Party Transactions (Textual)

Debt conversion price (in dollars per share)

$ 1

Warrant exercise price (in dollars per share)

$ 11.50

Promissory Note [Member] | Pensare Sponsor Group LLC (the "Sponsor") [Member] | Maximum [Member]

Related Party Transactions (Textual)

Principal amount

$ 750,000

Description of cash fees

The loans will be non-interest bearing, unsecured and payable upon the consummation of the Company’s initial business combination or at the holder’s discretion, up to $500,000 of the commitment may be convertible into warrants of the Company at a price of $1.00 per warrant. If the Company does not complete a business combination, any such loans will be forgiven.

Promissory Note [Member] | Pensare Sponsor Group LLC (the "Sponsor") [Member] | Warrant [Member]

Related Party Transactions (Textual)

Share price (in dollars per share)

$ 1

Subsequent Event [Member] | Pensare Sponsor Group LLC (the "Sponsor") [Member]

Related Party Transactions (Textual)

Trust account, description

Total monthly payment will be no greater than $200,000.

Sponsor [Member]

Related Party Transactions (Textual)

Description of working loans terms

The Working Capital Loans, evidenced by a promissory note, are payable without interest upon consummation of a Business Combination or, at the holder’s discretion, up to $1,500,000 of the notes may be converted into warrants (“Warrants”) at a conversion price of $1.00 per Warrant.

Administrative fees

$ 240,000

$ 160,000

Working capital purposes

$ 250,000

$ 150,000

$ 1,000,000

Description of loan

On January 16, 2019, the Company announced that the Sponsor had agreed to contribute to the Company as a loan $0.033 for each public share that was not redeemed in connection with the stockholder vote to approve an amendment to the Company's amended and restated certificate of incorporation to extend the date by which the Company has to consummate a business combination for an additional three months, from February 1, 2019 to May 1, 2019, for each calendar month (commencing on February 2, 2019 and on the second day of each subsequent month), or portion thereof, that is needed by the Company to complete a Business Combination from February 2, 2019 until May 1, 2019. On February 1, 2019, the Company signed a promissory note agreeing to pay up to $2,797,117 of advances to be made by the Sponsor to cover contribution payments due to the Trust Account. On April 29, 2019, the Company held a special meeting of stockholders at which time the stockholders of the Company approved an amendment to the Company's amended and restated certificate of incorporation to extend the date by which the Company has to consummate a business combination for an additional three months, from May 1, 2019 to August 1, 2019. On April 22, 2019, the Company announced that the Sponsor, had agreed to contribute as a loan, $0.033 for each share of common stock issued in the initial public offering that was not redeemed in connection with the stockholder vote to approve an amendment to the Company's amended and restated certificate of incorporation to extend the date by which they have to consummate a business combination for an additional three months, from May 1, 2019 to August 1, 2019. The contribution was deposited in the trust account established in connection with the Company's initial public offering. On May 9, 2019, the Company signed a promissory note agreeing to repay $805,916 for an advance made by the Sponsor as an additional contribution payment to the Trust Account.

Sponsor [Member] | Promissory Note [Member]

Related Party Transactions (Textual)

Interest rate terms

Payable without interest upon consummation of a Business Combination or, at the holder.

Working capital purposes

$ 317,628

Sponsor [Member] | Subsequent Event [Member]

Related Party Transactions (Textual)

Trust account, description

The Company announced that the Sponsor will reduce its contributions to the Trust Account. The Sponsor will continue to pay to the Trust Account $0.033 per public share that has not been redeemed per month, but the total monthly payment will be no greater than $200,000. If more than 6,060,606 public shares remain outstanding after redemptions in connection with this adjustment, then the amount paid per share will be reduced proportionately. In connection with this announcement, the Company offered the public stockholders the right to redeem their shares of common stock for their pro rata portion of the funds available in the Trust Account.

Initial Shareholder [Member]

Related Party Transactions (Textual)

Number of shares for dividend

575,000

Number of shares outstanding

7,762,500

Administrative fees

$ 20,000

MasTec, Inc. ("MasTec") [Member] | Pensare Sponsor Group LLC (the "Sponsor") [Member]

Related Party Transactions (Textual)

Number of shares transferred

1,575,000

Commitments (Details)

Commitments (Details)	12 Months Ended
	Mar. 31, 2019$ / shares
Share price (in dollars per share)	$ 0.033
EBC [Member]
Description of cash fees	The consummation of an initial Business Combination in an amount equal to 3.5% of the gross proceeds of the offering (exclusive of any applicable finders’ fees which might become payable); provided that the Company has the right to allocate up to 30% of the fee to any of the underwriters in the offering or other FINRA member firms the Company retains to assist it in connection with its initial Business Combination.

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($)	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Preferred stock, authorized	1,000,000	1,000,000
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, authorized	100,000,000	100,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	9,032,109	8,469,986
Common stock, shares outstanding	9,032,109	8,469,986
Common stock subject to possible redemption	26,984,101	30,342,514
EBC and co-underwriters [Member]
Stock options exercisable		13,500,000
Options exercise price	$ 13,500,000
Proceeds from units issued	$ 100
Option expire period	5 years
Warrant [Member]
Description of warrant redemption	The Company may redeem the Public Warrants (except with respect to the Placement Warrants): ● in whole and not in part; ● at a price of $0.01 per warrant; ● at any time during the exercise period; ● upon a minimum of 30 days’ prior written notice of redemption; ● if, and only if, the last sale price of the Company’s Common Stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; and ● if, and only if, there is a current registration statement in effect with respect to the shares of Common Stock underlying such warrants.
Purchase Option [Member]
Stock options exercise price	$ 10
Fair value of purchase unit options	$ 4,547,505
Fair value of purchase unit options	$ 3.37
Description of fair value assumptions	(1) expected volatility of 35%, (2) risk-free interest rate of 1.80% and (3) expected life of five years.
Deemed compensation term	The option and the 1,350,000 Units have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(g)(1) of FINRA’s NASDAQ Conduct Rules. Additionally, the option may not be sold, transferred, assigned, pledged or hypothecated for a one-year period (including the foregoing 180-day period) following the date of Offering except to any underwriter and selected dealer participating in the Offering and their bona fide officers or partners.
Option grants to holders demand period	5 years
Option grants to piggy back period	7 years

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($)	Mar. 31, 2019	Mar. 31, 2018
Fair Value, Measurements, Recurring [Member] | Level 1 [Member]
Assets:
Cash and marketable securities held in Trust Account	$ 290,454,757	$ 312,103,251

Income Tax (Details)

Income Tax (Details) - USD ($)	Mar. 31, 2019	Mar. 31, 2018
Deferred tax asset
Net operating loss carryforward	$ 378,831	$ 543,458
Total deferred tax assets	378,831	543,458
Valuation allowance	(162,831)	(543,458)
Deferred tax asset, net of allowance	$ 216,000

Income Tax (Details 1)

Income Tax (Details 1) - USD ($)	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Federal
Current
Deferred	(164,627)	543,458
State
Current	(163)	(183,998)
Deferred
Change in valuation allowance	380,627	(543,458)
Income tax benefit (provision)	$ (215,837)	$ 183,998

Income Tax (Details 2)

Income Tax (Details 2)	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Income Tax Disclosure [Abstract]
Statutory federal income tax rate	21.00%	0.00%
State taxes, net of federal tax benefit	2.00%	0.00%
Permanent items	0.27%	0.00%
Change in valuation allowance	(49.18%)	0.00%
State Franchise taxes	0.00%	7.88%
Income tax provision (benefit)	(27.89%)	7.88%

Income Tax (Details Textual)

Income Tax (Details Textual) - USD ($)	1 Months Ended	12 Months Ended
	Dec. 31, 2017	Mar. 31, 2019	Mar. 31, 2018
Operating Loss Carryforwards [Line Items]
Statutory federal income tax rate		21.00%	0.00%
Federal net operating loss carryforward		$ 1,804,000
Expires in year		Mar. 31, 2038
Maximum [Member]
Operating Loss Carryforwards [Line Items]
Statutory federal income tax rate	35.00%
Minimum [Member]
Operating Loss Carryforwards [Line Items]
Statutory federal income tax rate	21.00%

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	May 19, 2019	Apr. 19, 2019	May 31, 2019	May 19, 2019	Apr. 29, 2019	Apr. 22, 2019	Apr. 19, 2019	Jan. 28, 2019	Jun. 02, 2019	Mar. 31, 2019	Mar. 31, 2018
Number of common shares redeemed										$ (989,799)	$ (304,812,059)
Trust Account [Member]
Description of redemption settlement terms								The amendment was approved with 26,352,896 votes cast in favor of the amendment, 122,986 votes cast against the amendment and 323,175 abstentions. In connection with the special meeting and the resulting amendment to our amended and restated certificate of incorporation, 2,796,290 shares of our common stock were redeemed from funds available in the trust account established in connection with the Company’s initial public offering (the “Trust Account”), for a redemption amount of approximately $10.18 per share.
Trust Account [Member] | Initial Public Offering [Member]
Description of redemption settlement terms										The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then on deposit in the Trust Account, net of taxes payable (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants or rights. The Common Stock subject to redemption has been recorded at redemption value and classified as temporary equity upon the completion of the Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, in the case of a stockholder vote, a majority of the outstanding shares voted are voted in favor of the Business Combination.
Subsequent Event [Member]
Sponsor advanced				$ 250,000			$ 150,000
Subsequent Event [Member] | Initial Public Offering [Member]
Number of common shares redeemed (in dollars per share)						$ 0.033
Subsequent Event [Member] | Sponsor [Member]
Contribution as a loan (in dollars per share)			$ 0.033
Sponsor advanced	$ 250,000	$ 150,000							$ 1,938,349
Trust account, description			Total monthly payment will be no greater than $200,000.
Subsequent Event [Member] | Trust Account [Member]
Sponsor advanced									$ 1,938,349
Description of redemption settlement terms					The amendment was approved with 26,163,835 votes cast in favor of the amendment, 2,020,001 votes cast against the amendment and 422,075 abstentions. In connection with the special meeting and the resulting amendment to our amended and restated certificate of incorporation, 3,831,985 shares of our common stock were redeemed from funds available in the Trust Account, for a redemption amount of approximately $10.33 per share.